- Report
- May 2025
- 200 Pages
Global
From €2236EUR$2,490USD£1,904GBP
- Report
- June 2025
- 179 Pages
Global
From €5252EUR$5,850USD£4,473GBP
- Report
- June 2025
- 93 Pages
Global
From €5252EUR$5,850USD£4,473GBP
- Report
- June 2025
- 352 Pages
Global
From €5252EUR$5,850USD£4,473GBP
- Report
- June 2023
- 289 Pages
Global
From €4801EUR$5,534USD£3,950GBP
- Report
- January 2023
- 197 Pages
Global
From €4444EUR$4,950USD£3,785GBP
- Report
- September 2023
- 168 Pages
Global
From €5342EUR$5,950USD£4,549GBP
- Report
- March 2023
- 150 Pages
Global
From €5342EUR$5,950USD£4,549GBP
- Report
- February 2024
- 110 Pages
Global
From €4265EUR$4,750USD£3,632GBP
- Report
- October 2023
- 138 Pages
North America
From €3053EUR$3,400USD£2,600GBP
€3591EUR$4,000USD£3,058GBP
- Report
- January 2024
- 78 Pages
Global
From €3500EUR$4,176USD£3,085GBP
- Book
- February 2024
- 640 Pages
- Book
- October 2020
- 288 Pages
- Book
- June 2022
North America

Colon cancer is a type of cancer that affects the large intestine, or colon. It is the third most common type of cancer in the world and is the second leading cause of cancer-related deaths in the United States. In oncology, colon cancer is typically treated with a combination of surgery, chemotherapy, and radiation therapy. Surgery is the most common treatment, and it is used to remove the tumor and any affected lymph nodes. Chemotherapy and radiation therapy are used to kill any remaining cancer cells.
The colon cancer market is a rapidly growing segment of the oncology market. It is driven by the increasing prevalence of the disease, advances in treatment options, and the availability of new drugs. Companies in the market include AstraZeneca, Bristol-Myers Squibb, Eli Lilly, Merck, and Roche. Show Less Read more